Development of Novel Regimens Combining Immune Checkpoint Inhibitors and Radiation Therapy in Prostate Cancer

Eur Urol. 2022 Mar;81(3):263-265. doi: 10.1016/j.eururo.2021.11.024. Epub 2021 Dec 9.

Authors

Umang Swami¹, Nicolas Sayegh¹, Neeraj Agarwal²

Affiliations

¹ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
² Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu.

PMID: 34895788
DOI: 10.1016/j.eururo.2021.11.024

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immune Checkpoint Inhibitors*
Immunotherapy
Male
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / radiotherapy

Substances

Immune Checkpoint Inhibitors